RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2018

RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer

Dates et versions

hal-02143655 , version 1 (29-05-2019)

Identifiants

Citer

R. Sabatier, S. Garnier, N. Carbuccia, A. Guille, C. Tarpin, et al.. RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy316.001⟩. ⟨hal-02143655⟩

Collections

CNRS UNIV-AMU CRCM
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More